Neural basis of psychosis-related behaviour in the infection model of schizophrenia
Abstract
Maternal infection during pregnancy is a notable risk factor for the offspring to develop severe neuropsychiatric disorders, including schizophrenia. One prevalent hypothesis suggests that infection-induced disruption of early prenatal brain development predisposes the organism for long-lasting structural and functional brain abnormalities, leading to the emergence of psychopathological behaviour in adulthood. The feasibility of this causal link has received considerable support from several experimental models established in both rats and mice. In this review, we provide an integrative summary of the long-term neuropathological consequences of prenatal exposure to infection and/or inflammation as identified in various experimental models of prenatal immune challenge. In addition, we highlight how abnormalities in distinct brain areas and neurotransmitter systems following prenatal immune activation may provide a neural basis for the emergence of specific forms of psychosis-related behaviour. Specifically, we suggest that prenatal infection-induced imbalances in the mesolimibic and mesocortical dopamine pathways may constitute critical neural mechanisms for disturbances in sensorimotor gating, abnormalities in selective associative learning and hypersensitivity to psychostimulant drugs. On the other hand, the emergence of working memory deficiency following prenatal immune challenge may be crucially linked to the concomitant disruption of GABAergic and glutamatergic functions in prefrontal cortical and hippocampal structures. Notably, many of the identified neuronal abnormalities are directly implicated in the neuropathology of schizophrenia. The findings from prenatal infection models of schizophrenia thus provide considerable experimental evidence for the assumption that prenatal exposure to infection and/or inflammation is a relevant environmental link to specific neuronal abnormalities underlying psychosis-related behaviour in humans.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Inflammation and immune signaling dysregulation can strongly influence neuropsychiatric behavior beyond ASD, with roles in bipolar disorder and PTSD, and perhaps most emphatically in schizophrenia.
“Inflammation and immune signaling dysregulation can strongly influence neuropsychiatric behavior beyond just ASD (Haroon et al, 2012;Meyer and Feldon, 2009), with evidence pointing toward roles in bipolar disorder and PTSD (Jones and Thomsen, 2013), and perhaps most emphatically in schizophrenia (Brown et al, 2004b;Meyer and Feldon, 2009;Michel et al, 2012;Patterson, 2009).”
From The Role of the Immune System in Autism Spectrum Disorder (2017) · cites this paper as Meyer and Feldon, 2009
The vast majority of studies report decreased 5-HT synthesis and neuron number with prenatal inflammation regardless of developmental timing.
“the vast majority of studies report a decrease in 5-HT synthesis and neuron number with exposure to prenatal inflammation regardless of the developmental timing of the immune challenge (Meyer and Feldon, 2009).”
From Neuroinflammation as a risk factor for attention deficit hyperactivity disorder (2019) · cites this paper as Meyer and Feldon, 2009
Cites
Working memory: Looking back and looking forward
Baddeley, A. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1201 · Cited by 5,200 · see citing works
Implications of Normal Brain Development for the Pathogenesis of Schizophrenia
Weinberger, D. R. (1987) · Archives of General Psychiatry · doi:10.1001/archpsyc.1987.01800190080012 · Cited by 3,724 · see citing works
Morris, R. G. M., Anderson, E., Lynch, G. S., & Baudry, M. (1986) · Nature · doi:10.1038/319774a0 · Cited by 3,640 · see citing works
Krystal, J. H. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950030035004 · Cited by 3,330 · see citing works
Recent advances in the phencyclidine model of schizophrenia
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.10.1301 · Cited by 2,904 · see citing works
From motivation to action: Functional interface between the limbic system and the motor system
MOGENSON, G., JONES, D., & YIM, C. (1980) · Progress in Neurobiology · doi:10.1016/0301-0082(80)90018-0 · Cited by 2,331 · see citing works
Cortical inhibitory neurons and schizophrenia
Lewis, D. A., Hashimoto, T., & Volk, D. W. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1648 · Cited by 2,297 · see citing works
Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence
Harrison, P. J., & Weinberger, D. R. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001558 · Cited by 2,020 · see citing works
Genetic enhancement of learning and memory in mice
Tang, Y., Shimizu, E., Dubé, G., Rampon, C., Kerchner, G. A., Zhuo, M., Liu, G., & Tsien, J. Z. (1999) · Nature · doi:10.1038/43432 · Cited by 1,867 · see citing works
NMDA receptor subunits: diversity, development and disease
Cull-Candy, S., Brickley, S., & Farrant, M. (2001) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(00)00215-4 · Cited by 1,694 · see citing works
Maternal Immune Activation Alters Fetal Brain Development through Interleukin-6
Smith, S. E. P., Li, J., Garbett, K., Mirnics, K., & Patterson, P. H. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2178-07.2007 · Cited by 1,605 · see citing works
The neuropsychology of schizophrenia
Gray, J. A., Feldon, J., Rawlins, J. N. P., Hemsley, D. R., & Smith, A. D. (1991) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00065055 · Cited by 1,350 · see citing works
Self-citationLaruelle, M., Abi-Dargham, A., van Dyck, C. H., Gil, R., D'Souza, C. D., Erdos, J., McCance, E., Rosenblatt, W., Fingado, C., Zoghbi, S. S., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.17.9235 · Cited by 1,291 · see citing works
Koch, M. (1999) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00098-7 · Cited by 1,287 · see citing works
Guidotti, A., Auta, J., Davis, J. M., Gerevini, V. D. G., Dwivedi, Y., Grayson, D. R., Impagnatiello, F., Pandey, G. N., Pesold, C., Sharma, R. P., et al. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.11.1061 · Cited by 1,203 · see citing works
Adult Schizophrenia Following Prenatal Exposure to an Influenza Epidemic
Mednick, S. A. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800260109013 · Cited by 1,198 · see citing works
Dopamine and the regulation of cognition and attention
Nieoullon, A. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00011-4 · Cited by 1,131 · see citing works
Swerdlow, N. R., Geyer, M. A., & BRAFF, D. L. (2001) · Psychopharmacology · doi:10.1007/s002130100799 · Cited by 1,053 · see citing works
Serologic Evidence of Prenatal Influenza in the Etiology of Schizophrenia
Brown, A. S., Begg, M. D., Gravenstein, S., Schaefer, C. A., Wyatt, R. J., Bresnahan, M. A., Babulas, V. P., & Susser, E. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.8.774 · Cited by 1,048 · see citing works
Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring
Shi, L., Fatemi, S. H., Sidwell, R. W., & Patterson, P. H. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-01-00297.2003 · Cited by 1,025 · see citing works
Akbarian, S. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950160008002 · Cited by 1,002 · see citing works
The neurodevelopmental model of schizophrenia: update 2005
Rapoport, J. L., Addington, A. M., Frangou, S., & Psych, M. R. C. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001642 · Cited by 993 · see citing works
Hashimoto, T., Volk, D. W., Eggan, S. M., Mirnics, K., Pierri, J. N., Sun, Z., Sampson, A. R., & Lewis, D. A. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-15-06315.2003 · Cited by 938 · see citing works
Spatial memory and hippocampal function
Olton, D. S., & Paras, B. C. (1979) · Neuropsychologia · doi:10.1016/0028-3932(79)90042-3 · Cited by 927 · see citing works
Defined types of cortical interneurone structure space and spike timing in the hippocampus
Somogyi, P., & Klausberger, T. (2005) · The Journal of Physiology · doi:10.1113/jphysiol.2004.078915 · Cited by 927 · see citing works
Subanesthetic Doses of Ketamine Stimulate Psychosis in Schizophrenia
Lahti, A. C., Koffel, B., LaPorte, D. J., & Tamminga, C. A. (1995) · Neuropsychopharmacology · doi:10.1016/0893-133x(94)00131-i · Cited by 921 · see citing works
Moser, E., Moser, M. ‐., & Andersen, P. N. (1993) · Journal of Neuroscience · doi:10.1523/jneurosci.13-09-03916.1993 · Cited by 916 · see citing works
The Emerging Role of Glutamate in the Pathophysiology and Treatment of Schizophrenia
GOFF, D. C., & Coyle, J. T. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.9.1367 · Cited by 914 · see citing works
Spatial learning with a minislab in the dorsal hippocampus.
Moser, M., Moser, E. I., Forrest, E., Andersen, P. N., & Morris, R. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.21.9697 · Cited by 902 · see citing works
Benes, F. M. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810350036005 · Cited by 894 · see citing works
The Dopamine Hypothesis of Schizophrenia: A Review*
Meltzer, H. Y., & Stahl, S. M. (1976) · Schizophrenia Bulletin · doi:10.1093/schbul/2.1.19 · Cited by 883 · see citing works
Dopamine receptors and the dopamine hypothesis of schizophrenia
Seeman, P. M. (1987) · Synapse · doi:10.1002/syn.890010203 · Cited by 880 · see citing works
Groenewegen, H. J., Vermeulen‐Vanderzee, E., Kortschot, A. T., & Witter, M. P. (1987) · Neuroscience · doi:10.1016/0306-4522(87)90275-2 · Cited by 867 · see citing works
Meyer, U., Nyffeler, M., Engler, A., Urwyler, A., Schedlowski, M., Knuesel, I., Yee, B. K., & Feldon, J. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.0099-06.2006 · Cited by 774 · see citing works
Self-citationA decrease of reelin expression as a putative vulnerability factor in schizophrenia
Impagnatiello, F., Guidotti, A. R., Pesold, C., Dwivedi, Y., Caruncho, H. J., Pisu, M. G., Uzunov, D. P., Smalheiser, N. R., Davis, J. M., Pandey, G. N., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15718 · Cited by 753 · see citing works
Increased dopamine transmission in schizophrenia: relationship to illness phases.
Laruelle, M., Abi-Dargham, A., Gil, R. B., Kegeles, L., & Innis, R. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00067-0 · Cited by 744 · see citing works
Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence.
Carlsson, A., Waters, N., Holm-Waters, S., Tedroff, J., Nilsson, M., & Carlsson, M. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.237 · Cited by 742 · see citing works
Prefrontal Dopamine D<sub>1</sub>Receptors and Working Memory in Schizophrenia
Abi-Dargham, A., Mawlawi, O., Lombardo, I., Gil, R., Martinez, D., Huang, Y., Hwang, D.-R., Keilp, J., Kochan, L., Van Heertum, R., et al. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-09-03708.2002 · Cited by 724 · see citing works
Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET
Okubo, Y., Suhara, T., Suzuki, K., Kobayashi, K., Inoue, O., Terasaki, O., Someya, Y., Sassa, T., Sudo, Y., Matsushima, E., et al. (1997) · Nature · doi:10.1038/385634a0 · Cited by 710 · see citing works
Ross, C. A., Margolis, R. L., Reading, S. A. J., Pletnikov, M. V., & Coyle, J. T. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.015 · Cited by 697 · see citing works
Volk, D. W., Austin, M. C., Pierri, J. N., Sampson, A. R., & Lewis, D. A. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.3.237 · Cited by 697 · see citing works
To Model a Psychiatric Disorder in Animals Schizophrenia As a Reality Test
Lipska, B. K. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00137-8 · Cited by 650 · see citing works
Swerdlow, N. R., & Geyer, M. A. (1998) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033326 · Cited by 616 · see citing works
Joel, D., & Weiner, I. (2000) · Neuroscience · doi:10.1016/s0306-4522(99)00575-8 · Cited by 614 · see citing works
Genes, dopamine and cortical signal-to-noise ratio in schizophrenia
Winterer, G., & Weinberger, D. R. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.08.002 · Cited by 598 · see citing works
Infections of the Central Nervous System
Townsend, G. C., & Scheld, W. M. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-5-415_1 · Cited by 594 · see citing works
Neural synchrony indexes disordered perception and cognition in schizophrenia
Spencer, K., Nestor, P. G., Perlmutter, R., Niznikiewicz, M. A., Klump, M. C., Frumin, M., Shenton, M. E., & McCarley, R. W. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406074101 · Cited by 591 · see citing works
The pharmacological and anatomical substrates of the amphetamine response in the rat
Creese, I., & Iversen, S. D. (1975) · Brain Research · doi:10.1016/0006-8993(75)90834-3 · Cited by 583 · see citing works
Glutamatergic mechanisms in schizophrenia
Tsai, G., & Coyle, J. T. (2002) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.42.082701.160735 · Cited by 577 · see citing works
Effects of chemical stimulation of the mesolimbic dopamine system upon locomotor activity
Pijnenburg, A. J. J., Honig, W. M. M., van Rossum, J. M., & van Rossum, J. M. (1976) · European Journal of Pharmacology · doi:10.1016/0014-2999(76)90299-5 · Cited by 563 · see citing works
The dopamine hypothesis of schizophrenia: focus on the dopamine receptor
Snyder, S. H. (1976) · American Journal of Psychiatry · doi:10.1176/ajp.133.2.197 · Cited by 557 · see citing works
Prenatal Infection as a Risk Factor for Schizophrenia
Brown, A. S. (2006) · Schizophrenia Bulletin · doi:10.1093/schbul/sbj052 · Cited by 540 · see citing works
Davis, S., Butcher, S., & Morris, R. (1992) · Journal of Neuroscience · doi:10.1523/jneurosci.12-01-00021.1992 · Cited by 539 · see citing works
Provocative tests with psychostimulant drugs in schizophrenia
Lieberman, J. A., Kane, J. M., & Alvir, J. (1987) · Psychopharmacology · doi:10.1007/bf00216006 · Cited by 535 · see citing works
The acoustic startle response in rats—circuits mediating evocation, inhibition and potentiation
Koch, M., & Schnitzler, H. U. (1997) · Behavioural Brain Research · doi:10.1016/s0166-4328(97)02296-1 · Cited by 521 · see citing works
A Neurodevelopmental Approach to the Classification of Schizophrenia
Murray, R. M., O’Callaghan, E., Castle, D. J., & Lewis, S. W. (1992) · Schizophrenia Bulletin · doi:10.1093/schbul/18.2.319 · Cited by 516 · see citing works
Maternal Infections and Subsequent Psychosis Among Offspring
Buka, S. L. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.11.1032 · Cited by 512 · see citing works
Cai, Z., Pan, Z.-L., Pang, Y., Evans, O. B., & Rhodes, P. G. (2000) · Pediatric Research · doi:10.1203/00006450-200001000-00013 · Cited by 507 · see citing works
Hippocampal CA3 NMDA Receptors Are Crucial for Memory Acquisition of One-Time Experience
Nakazawa, K., Sun, L. D., Quirk, M. C., Rondi‐Reig, L., Wilson, M. A., & Tonegawa, S. (2003) · Neuron · doi:10.1016/s0896-6273(03)00165-x · Cited by 506 · see citing works
Zuckerman, L., Rehavi, M., Nachman, R., & Weiner, I. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300248 · Cited by 501 · see citing works
Towards an immuno-precipitated neurodevelopmental animal model of schizophrenia
Meyer, U., Feldon, J., Schedlowski, M., & Yee, B. K. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2004.10.012 · Cited by 494 · see citing works
Self-citationMaternal Exposure to Toxoplasmosis and Risk of Schizophrenia in Adult Offspring
Brown, A. S., Schaefer, C. A., Quesenberry, C. P., Liu, L., Babulas, V. P., & Susser, E. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.4.767 · Cited by 490 · see citing works
Hashimoto, T., Arion, D., Unger, T., Maldonado-Avilés, J. G., Morris, H. M., Volk, D. W., Mirnics, K., & Lewis, D. A. (2008) · Molecular Psychiatry · doi:10.1038/sj.mp.4002011 · Cited by 490 · see citing works
Pharmacology of mesocortical dopamine neurons.
Bannon, M. J., & Roth, R. H. (1983) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06572-x · Cited by 488 · see citing works
Robertson, G. S., & Fibiger, H. C. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90054-6 · Cited by 474 · see citing works
Ozawa, K., Hashimoto, K., Kishimoto, T., Shimizu, E., Ishikura, H., & Iyo, M. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.07.031 · Cited by 467 · see citing works
Meyer, U., Nyffeler, M., Yee, B. K., Knuesel, I., & Feldon, J. (2008) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2007.09.012 · Cited by 457 · see citing works
Self-citationGlutamate, Dopamine, and Schizophrenia: From Pathophysiology to Treatment
LARUELLE, M., KEGELES, L. S., & ABI‐DARGHAM, A. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1300.063 · Cited by 437 · see citing works
Serotonin research: contributions to understanding psychoses
GEYER, M., & VOLLENWEIDER, F. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.06.006 · Cited by 427 · see citing works
Development of neurotransmitter systems during critical periods
Herlenius, E., & Lagercrantz, H. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.03.027 · Cited by 426 · see citing works
Parvalbumin-immunoreactive neurons are reduced in the prefrontal cortex of schizophrenics
BEASLEY, C., & REYNOLDS, G. (1997) · Schizophrenia Research · doi:10.1016/s0920-9964(96)00122-3 · Cited by 426 · see citing works
The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice
Carlsson, M., & Carlsson, A. (1989) · Journal of Neural Transmission · doi:10.1007/bf01258633 · Cited by 423 · see citing works
A subclass of prefrontal γ-aminobutyric acid axon terminals are selectively altered in schizophrenia
Woo, T.-U. W., Whitehead, R. E., Melchitzky, D. S., & Lewis, D. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.9.5341 · Cited by 410 · see citing works
Glutamate and GABA receptor signalling in the developing brain
Luján, R., Shigemoto, R., & López‐Bendito, G. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.09.042 · Cited by 409 · see citing works
Increased Brain Dopamine and Dopamine Receptors in Schizophrenia
Mackay, A. V. P. (1982) · Archives of General Psychiatry · doi:10.1001/archpsyc.1982.04290090001001 · Cited by 399 · see citing works
Bannerman, D. M., Yee, B. K., Good, M. A., Heupel, M. J., Iversen, S. D., & Rawlins, J. N. P. (1999) · Behavioral Neuroscience · doi:10.1037/0735-7044.113.6.1170 · Cited by 397 · see citing works
Weiner, I. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1313-x · Cited by 387 · see citing works
Ashdown, H. F., Dumont, Y., Ng, M., Poole, S., Boksa, P., & Luheshi, G. N. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001748 · Cited by 387 · see citing works
Cytokine Actions in the Central Nervous System
Benveniste, E. N. (1998) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(98)00015-x · Cited by 383 · see citing works
Increased GABAA receptor binding in superficial layers of cingulate cortex in schizophrenics
Benes, F., Vincent, S. L., Alsterberg, G., Bird, E. D., & SanGiovanni, J. (1992) · Journal of Neuroscience · doi:10.1523/jneurosci.12-03-00924.1992 · Cited by 367 · see citing works
Neurobiology of Dopamine in Schizophrenia
Guillin, O., Abi‐Dargham, A., & Laruelle, M. (2007) · International Review of Neurobiology · doi:10.1016/s0074-7742(06)78001-1 · Cited by 365 · see citing works
Maternal immune activation leads to behavioral and pharmacological changes in the adult offspring
Zuckerman, L., & Weiner, I. (2004) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2004.08.008 · Cited by 352 · see citing works
NMDA receptor function: subunit composition versus spatial distribution
Köhr, G. (2006) · Cell and Tissue Research · doi:10.1007/s00441-006-0273-6 · Cited by 335 · see citing works
Chapter 14 Descending motor pathways and the spinal motor system: Limbic and non-limbic components
Holstege, G. (1991) · Progress in brain research · doi:10.1016/s0079-6123(08)63057-5 · Cited by 323 · see citing works
A Review of the Fetal Brain Cytokine Imbalance Hypothesis of Schizophrenia
Meyer, U., Feldon, J., & Yee, B. K. (2008) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn022 · Cited by 318 · see citing works
Self-citationModeling madness in mice: one piece at a time
Arguello, P. A., & Gogos, J. A. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.023 · Cited by 309 · see citing works
Borrell, J. I. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00360-8 · Cited by 307 · see citing works
Meyer, U., Yee, B. K., & Feldon, J. (2007) · The Neuroscientist · doi:10.1177/1073858406296401 · Cited by 303 · see citing works
Self-citationPrenatal rubella, premorbid abnormalities, and adult schizophrenia
Brown, A. S., Cohen, P., Harkavy‐Friedman, J., Babulas, V. P., Malaspina, D., Gorman, J., & Susser, E. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01068-x · Cited by 298 · see citing works
Samuelsson, A., Jennische, E., Hansson, H., & Holmäng, A. B. (2005) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00268.2005 · Cited by 283 · see citing works
Prefrontal DA Transmission at D1 Receptors and the Pathology of Schizophrenia
Abi‐Dargham, A., & Moore, H. M. (2003) · The Neuroscientist · doi:10.1177/1073858403252674 · Cited by 275 · see citing works
Pothuizen, H. H. J., Zhang, W., Jongen‐Rêlo, A. L., Feldon, J., & Yee, B. K. (2004) · European Journal of Neuroscience · doi:10.1111/j.0953-816x.2004.03170.x · Cited by 274 · see citing works
Self-citationBenes, F. M., Vincent, S. L., Marie, A. S., & Khan, Y. (1996) · Neuroscience · doi:10.1016/0306-4522(96)00328-4 · Cited by 274 · see citing works
Mortensen, P. B., Nørgaard‐Pedersen, B., Waltoft, B. L., Sørensen, T. L., HOUGAARD, D. M., Torrey, E. F., & Yolken, R. H. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.05.024 · Cited by 269 · see citing works
Hippocampal modulation of sensorimotor processes.
Bast, T., & Feldon, J. (2003) · Progress in neurobiology · doi:10.1016/s0301-0082(03)00112-6 · Cited by 267 · see citing works
Self-citationTotterdell, S., & Smith, A. D. (1989) · PubMed · Cited by 266 · see citing works
Volk, D. W. (2002) · Cerebral Cortex · doi:10.1093/cercor/12.10.1063 · Cited by 264 · see citing works
Fatemi, S. H., Earle, J., Kanodia, R., Kist, D., Emamian, E. S., Patterson, P. H., Shi, L., & Sidwell, R. (2002) · Cellular and Molecular Neurobiology · doi:10.1023/a:1015337611258 · Cited by 261 · see citing works
In utero infection and adult schizophrenia
Brown, A. S., & Susser, E. (2002) · Mental Retardation and Developmental Disabilities Research Reviews · doi:10.1002/mrdd.10004 · Cited by 261 · see citing works
Meyer, U., Feldon, J., Schedlowski, M., & Yee, B. K. (2005) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2005.11.003 · Cited by 260 · see citing works
Self-citationFatemi, S. H., Emamian, E. S., Kist, D. A., Sidwell, R. W., Nakajima, K., Akhter, P., Shier, A. C., Sheikh, S. A., & Bailey, K. W. (1999) · Molecular Psychiatry · doi:10.1038/sj.mp.4000520 · Cited by 259 · see citing works
Golan, H. M., Lev, V., Hallak, M., Sorokin, Y., & Huleihel, M. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.12.023 · Cited by 253 · see citing works
Meyer, U., Murray, P. J., Urwyler, A., Yee, B. K., Schedlowski, M., & Feldon, J. (2008) · Molecular Psychiatry · doi:10.1038/sj.mp.4002042 · Cited by 252 · see citing works
Self-citationFatemi, S. H., Reutiman, T. J., Folsom, T. D., Huang, H., Oishi, K., Mori, S., Smee, D. F., Pearce, D. A., Winter, C., Sohr, R., et al. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2007.11.018 · Cited by 250 · see citing works
Winter, C., Djodari-Irani, A., Sohr, R., Morgenstern, R., Feldon, J., Juckel, G., & Meyer, U. (2009) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708009206 · Cited by 242 · see citing works
Self-citationReelin glycoprotein: structure, biology and roles in health and disease
Fatemi, S. H. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001613 · Cited by 241 · see citing works
Mogenson, G. J., & Yang, C. R. (1991) · Advances in experimental medicine and biology · doi:10.1007/978-1-4757-0145-6_14 · Cited by 238 · see citing works
Prenatal Exposure to Maternal Genital and Reproductive Infections and Adult Schizophrenia
Babulas, V. P., Factor-Litvak, P. R., Goetz, R. R., Schaefer, C. A., & Brown, A. S. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.5.927 · Cited by 233 · see citing works
Fortier, M., Luheshi, G. N., & Boksa, P. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.04.016 · Cited by 229 · see citing works
Deutch, A. Y. (1992) · Springer eBooks · doi:10.1007/978-3-7091-9211-5_5 · Cited by 221 · see citing works
Meyer, U., Nyffeler, M., Schwendener, S., Knuesel, I., Yee, B. K., & Feldon, J. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301413 · Cited by 215 · see citing works
Self-citationSchizophrenia as an inflammation-mediated dysbalance of glutamatergic neurotransmission
Müller, N., & Schwarz, M. (2006) · Neurotoxicity Research · doi:10.1007/bf03033242 · Cited by 214 · see citing works
The role of serotonin in the pathophysiology and treatment of schizophrenia
Abi‐Dargham, A., Laruelle, M. A., Aghajanian, G. K., Charney, D. S., & Krystal, J. H. (1997) · Journal of Neuropsychiatry · doi:10.1176/jnp.9.1.1 · Cited by 210 · see citing works
Niewoehner, B., Single, F. N., Hvalby, Ø., Jensen, V., Borgloh, S. M. Z. A., SEEBURG, P. H., Rawlins, J. N. P., Sprengel, R., & Bannerman, D. M. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05312.x · Cited by 209 · see citing works
Exposure to infection and brain development: cytokines in the pathogenesis of schizophrenia
GILMORE, J., & FREDRIKJARSKOG, L. (1997) · Schizophrenia Research · doi:10.1016/s0920-9964(96)00123-5 · Cited by 209 · see citing works
The Neurobiology of Cognition in Schizophrenia
Tamminga, C. A. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.0906e11 · Cited by 198 · see citing works
Bannerman, D. M., Niewoehner, B., Lyon, L., Romberg, C., Schmitt, W. B., Taylor, A. M., Sanderson, D. J., Cottam, J. C. H., Sprengel, R., Seeburg, P. H., et al. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.3639-07.2008 · Cited by 197 · see citing works
Prepulse inhibition and latent inhibition: the role of dopamine in the medial prefrontal cortex
Ellenbroek, B. A., Budde, S., & Cools, A. R. (1996) · Neuroscience · doi:10.1016/0306-4522(96)00307-7 · Cited by 197 · see citing works
Association Between Prenatal Exposure to Poliovirus Infection and Adult Schizophrenia
Suvisaari, J., Haukka, J. K., Tanskanen, A. J., Hovi, T., & Lönnqvist, J. K. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.7.1100 · Cited by 192 · see citing works
Schizophrenia and the parvalbumin-containing class of cortical local circuit neurons
Woo, T., Miller, J. L., & Lewis, D. A. (1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.7.1013 · Cited by 191 · see citing works
Toru, M., Watanabe, S., Shibuya, H., Nishikawa, T., Noda, K., Mitsushio, H., Ichikawa, H., Kurumaji, A., Takashima, M., Mataga, N., et al. (1988) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1988.tb06312.x · Cited by 191 · see citing works
The NMDA Receptor Hypofunction Model of Psychosis
Farber, N. B. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1300.008 · Cited by 190 · see citing works
Lewis, D. A., Cruz, D. A., Melchitzky, D. S., & Pierri, J. N. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.9.1411 · Cited by 190 · see citing works
Fortier, M., Joober, R., Luheshi, G., & Boksa, P. (2004) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2003.10.001 · Cited by 186 · see citing works
Schizophrenic births and viral diseases in two states
Torrey, Ε. F., Rawlings, R. R., & Waldman, I. N. (1988) · Schizophrenia Research · doi:10.1016/0920-9964(88)90043-6 · Cited by 185 · see citing works
Environmental risk factors for psychosis
Dean, K., & Murray, R. M. (2005) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2005.7.1/kdean · Cited by 185 · see citing works
Maternal Effects on Schizophrenia Risk
Patterson, P. H. (2007) · Science · doi:10.1126/science.1150196 · Cited by 175 · see citing works
Prenosil, G., Gasser, E. M. S., Rudolph, U., Keist, R., Fritschy, J., & Vogt, K. E. (2006) · Journal of Neurophysiology · doi:10.1152/jn.01199.2005 · Cited by 169 · see citing works
Early and late environmental risk factors for schizophrenia.
Mcdonald, C., & Murray, R. (2000) · Brain research. Brain research reviews · doi:10.1016/s0165-0173(99)00030-2 · Cited by 167 · see citing works
Romero, E., Guaza, C., Castellano, B., & Borrell, J. I. (2008) · Molecular Psychiatry · doi:10.1038/mp.2008.44 · Cited by 165 · see citing works
Does dopamine play a role in schizophrenia?
Carlsson, A. (1977) · Psychological Medicine · doi:10.1017/s003329170000622x · Cited by 163 · see citing works
Del Arco, A., & Mora, F. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.04.011 · Cited by 163 · see citing works
Lacroix, L. P., Broersen, L. M., Weiner, I., & Feldon, J. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00521-6 · Cited by 161 · see citing works
Self-citationGrant, K. A., Shively, C. A., Nader, M. A., Ehrenkaufer, R. L., Line, S. W., Morton, T. E., Gage, H. D., & Mach, R. H. (1998) · Synapse · doi:10.1002/(sici)1098-2396(199805)29:1 · Cited by 160 · see citing works
Impaired prefrontal inhibition in schizophrenia: relevance for cognitive dysfunction
Volk, D. W., & Lewis, D. A. (2002) · Physiology & Behavior · doi:10.1016/s0031-9384(02)00936-8 · Cited by 154 · see citing works
Changes in Serotonin2A and GABAA Receptors in Schizophrenia
Dean, B., Hussain, T., Hayes, W., Scarr, E., Kitsoulis, S., Hill, C., Opeskin, K., & Copolov, D. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.721593.x · Cited by 148 · see citing works
Prenatal activation of microglia induces delayed impairment of glutamatergic synaptic function
Roumier, A., Pascual, O., Béchade, C., Wakselman, S., Poncer, J.-C., Réal, E., Triller, A., & Bessis, A. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002595 · Cited by 146 · see citing works
Weiner, I., Gal, G., Rawlins, J. N. P., & Feldon, J. (1996) · Behavioural Brain Research · doi:10.1016/s0166-4328(96)00051-4 · Cited by 146 · see citing works
Self-citationDopaminergic Modulation of Prefrontal Cortical Input to Nucleus Accumbens NeuronsIn Vivo
Brady, A. M., & O’Donnell, P. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.4178-03.2004 · Cited by 143 · see citing works
[3H]Muscimol binding sites increased in autopsied brains of chronic schizophrenics
Hanada, S., Mita, T., Nishino, N., & Tanaka, C. (1987) · Life Sciences · doi:10.1016/0024-3205(87)90341-9 · Cited by 140 · see citing works
Nyffeler, M., Meyer, U., Yee, B. K., Feldon, J., & Knuesel, I. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.07.029 · Cited by 139 · see citing works
Self-citationReynolds, G. P., Zhang, Z. J., & Beasley, C. L. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00526-3 · Cited by 138 · see citing works
Romero, E., Ali, C., Molina‐Holgado, E., Castellano, B., Guaza, C., & Borrell, J. I. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301292 · Cited by 138 · see citing works
Prenatal exposure to influenza as a risk factor for adult schizophrenia
Limosin, F., Rouillon, F., Payan, C., Cohen, J., & Strub, N. (2003) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2003.00052.x · Cited by 137 · see citing works
Vezina, P., Blanc, G., Glowinski, J., & Tassin, J. (1991) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1991.tb00036.x · Cited by 135 · see citing works
Yan, Q., Reith, M. E. A., Jobe, P. C., & Dailey, J. W. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00568-4 · Cited by 131 · see citing works
Makinodan, M., Tatsumi, K., Manabe, T., Yamauchi, T., Makinodan, E., Matsuyoshi, H., Shimoda, S., Noriyama, Y., Kishimoto, T., & Wanaka, A. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21673 · Cited by 130 · see citing works
Prenatal and postnatal maternal contributions in the infection model of schizophrenia
Meyer, U., Schwendener, S., Feldon, J., & Yee, B. K. (2006) · Experimental Brain Research · doi:10.1007/s00221-006-0419-5 · Cited by 128 · see citing works
Self-citationFrench, E. D., Mura, A., & Wang, T. (1993) · Synapse · doi:10.1002/syn.890130203 · Cited by 125 · see citing works
Immune activation during mid-gestation disrupts sensorimotor gating in rat offspring
Wolff, A. R., & Bilkey, D. K. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.02.021 · Cited by 124 · see citing works
Prazosin inhibits MK-801-induced hyperlocomotion and dopamine release in the nucleus accumbens
Mathé, J. M., Nomikos, G. G., Hildebrand, B. E., Hertel, P., & Svensson, T. H. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(96)00315-9 · Cited by 122 · see citing works
Prefrontal cortex inputs of the nucleus accumbens-nigro-thalamic circuit
Montaron, M., Deniau, J., Menetrey, A., Glowinski, J., & Thierry, A. M. (1996) · Neuroscience · doi:10.1016/0306-4522(95)00455-6 · Cited by 121 · see citing works
Taepavarapruk, P., Floresco, S., & Phillips, A. G. (2000) · Psychopharmacology · doi:10.1007/s002130000376 · Cited by 121 · see citing works
Limbic/mesolimbic connections and the pathogenesis of schizophrenia
Csernansky, J. G., Murphy, G. M., & Faustman, W. O. (1991) · Biological Psychiatry · doi:10.1016/0006-3223(91)90295-w · Cited by 120 · see citing works
Post-pubertal emergence of disrupted latent inhibition following prenatal immune activation
Zuckerman, L., & Weiner, I. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1461-7 · Cited by 119 · see citing works
Fatemi, S. H., Emamian, E. S., Sidwell, R. W., Kist, D. A., Stary, J. M., Earle, J. A., & THURAS, P. D. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001046 · Cited by 116 · see citing works
Schizophrenia: New Pathological Insights and Therapies
Jarskog, L. F., Miyamoto, S., & Lieberman, J. A. (2007) · Annual Review of Medicine · doi:10.1146/annurev.med.58.060904.084114 · Cited by 116 · see citing works
Chapter 28 Theories of basal forebrain organization and the “emotional motor system”
Alheid, G. F., & Heimer, L. (1996) · Progress in brain research · doi:10.1016/s0079-6123(08)61882-8 · Cited by 115 · see citing works
Risk factors for schizophrenia — All roads lead to dopamine
Forti, M. D., Lappin, J., & Murray, R. M. (2007) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2007.02.005 · Cited by 113 · see citing works
Neuronal calcium-binding proteins and schizophrenia
Eyles, D. W., McGrath, J. J., & Reynolds, G. P. (2002) · Schizophrenia Research · doi:10.1016/s0920-9964(01)00299-7 · Cited by 113 · see citing works
Murase, S., Math�, J. M., Grenhoff, J., & Svensson, T. H. (1993) · Journal of Neural Transmission · doi:10.1007/bf01244915 · Cited by 109 · see citing works
Prenatal viral infection causes alterations in nNOS expression in developing mouse brains
Fatemi, S. H., Cuadra, A. E., El‐Fakahany, E. E., Sidwell, R. W., & THURAS, P. D. (2000) · Neuroreport · doi:10.1097/00001756-200005150-00027 · Cited by 109 · see citing works
Dopamine is not Required for the Hyperlocomotor Response to NMDA Receptor Antagonists
Chartoff, E. H., Heusner, C. L., & Palmiter, R. D. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300678 · Cited by 107 · see citing works
Holstege, G., Mouton, L. J., & Gerrits, P. O. (2004) · Elsevier eBooks · doi:10.1016/b978-012547626-3/50037-5 · Cited by 104 · see citing works
Topographical organization of projections from the entorhinal cortex to the striatum of the rat
Totterdell, S., & Meredith, G. E. (1997) · Neuroscience · doi:10.1016/s0306-4522(96)00592-1 · Cited by 101 · see citing works
Chronic Exposure to Intra-Amniotic Lipopolysaccharide Affects the Ovine Fetal Brain
Nitsos, I., Rees, S. M., Duncan, J., Kramer, B. W. W., Harding, R., Newnham, J. P., & Moss, T. J. M. (2006) · Journal of the Society for Gynecologic Investigation · doi:10.1016/j.jsgi.2006.02.011 · Cited by 99 · see citing works
Alterations of Serotonin Transmission in Schizophrenia
Abi‐Dargham, A. (2007) · International review of neurobiology · doi:10.1016/s0074-7742(06)78005-9 · Cited by 98 · see citing works
Winter, C., Reutiman, T. J., Folsom, T. D., Sohr, R., Wolf, R. J., Juckel, G., & Fatemi, S. H. (2008) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2008.06.001 · Cited by 92 · see citing works
Lacroix, L. P., Broersen, L. M., Feldon, J., & Weiner, I. (2000) · Behavioural Brain Research · doi:10.1016/s0166-4328(99)00118-7 · Cited by 89 · see citing works
Self-citationMaternal infection during pregnancy and schizophrenia
Boksa, P. (2008) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0818 · Cited by 83 · see citing works
Modulation of the Mesolimbic Dopamine System by Glutamate
Kretschmer, B. D. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0730839.x · Cited by 82 · see citing works
Bacopoulos, N. G., & BHATNAGAR, R. K. (1977) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1977.tb07780.x · Cited by 82 · see citing works
Stability of [123I]IBZM SPECT measurement of amphetamine-induced striatal dopamine release in humans
Kegeles, L. S., Zea‐Ponce, Y., Abi‐Dargham, A., Rodenhiser, J., Wang, T., Weiss, R., Heertum, R. L. V., Mann, J. J., & Laruelle, M. (1999) · Synapse · doi:10.1002/(sici)1098-2396(19990315)31:4 · Cited by 80 · see citing works
Aronsson, F. S., Lannebo, C., Paucar, M., Brask, J., Kristensson, K., & Karlsson, H. (2002) · Journal of NeuroVirology · doi:10.1080/13550280290100480 · Cited by 77 · see citing works
Bast, T., Zhang, W.-N., & Feldon, J. (2001) · Psychopharmacology · doi:10.1007/s002130100775 · Cited by 73 · see citing works
Zhang, W.-N., Pothuizen, H. H. J., Feldon, J., & Rawlins, J. N. P. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.05.007 · Cited by 67 · see citing works
Self-citationPeleg‐Raibstein, D., & Feldon, J. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.06.002 · Cited by 67 · see citing works
Self-citationBroersen, L. M., Feldon, J., & Weiner, I. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00287-0 · Cited by 65 · see citing works
Self-citationFetal Environment and Schizophrenia
Opler, M. G. A., & Susser, E. (2005) · Environmental Health Perspectives · doi:10.1289/ehp.7572 · Cited by 65 · see citing works
Zhang, W., Bast, T., & Feldon, J. (2002) · Behavioral Neuroscience · doi:10.1037//0735-7044.116.1.72 · Cited by 62 · see citing works
Self-citationReelin Glycoprotein in Autism and Schizophrenia
Fatemi, S. H. (2005) · International review of neurobiology · doi:10.1016/s0074-7742(05)71008-4 · Cited by 59 · see citing works
Bast, T., Zhang, W.-N., Heidbreder, C. A., & Feldon, J. (2001) · Neuroscience · doi:10.1016/s0306-4522(00)00589-3 · Cited by 58 · see citing works
Self-citationDopamine metabolism increases in post-mortem schizophrenic basal ganglia
Toru, M., Nishikawa, T., Mataga, N., & Takashima, M. (1982) · Journal of Neural Transmission · doi:10.1007/bf01254928 · Cited by 57 · see citing works
Hutton, L. C., Castillo-Meléndez, M., Smythe, G. A., & Walker, D. W. (2008) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2007.06.035 · Cited by 54 · see citing works
Prefrontal D1 and ventral hippocampal N-methyl-d-aspartate regulation of startle gating in rats
Shoemaker, J. M., Marie, R. L. S., Bongiovanni, M. J., Neary, A. C., Tochen, L. S., & Swerdlow, N. R. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.06.054 · Cited by 47 · see citing works
Broersen, L. M. (2000) · Progress in brain research · doi:10.1016/s0079-6123(00)26008-1 · Cited by 45 · see citing works
Möhler, H., Rudolph, U., Boison, D., Singer, P., Feldon, J., & Yee, B. K. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.03.003 · Cited by 44 · see citing works
Self-citationVezina, P., Blanc, G., Glowinski, J., & Tassin, J. (1994) · Synapse · doi:10.1002/syn.890160204 · Cited by 42 · see citing works
Fatemi, S. H. (2003) · Schizophrenia Research · doi:10.1016/s0920-9964(03)00175-0 · Cited by 40 · see citing works
Neuropsychiatric Disorders and Infection
Fatemi, S. H. (2005) · CRC Press eBooks · doi:10.3109/9780203007648 · Cited by 40 · see citing works
Regionally specific effects of haloperidol and clozapine on dopamine reuptake in the striatum
Rothblat, D. S., & Schneider, J. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00377-7 · Cited by 39 · see citing works
DOPAMINE RECEPTORS AND SCHIZOPHRENIA: DRUG EFFECT OR ILLNESS
Reynolds, G. P., Reynolds, L. M., Riederer, P. F., et al. (1980) · The Lancet · doi:10.1016/s0140-6736(80)92513-1 · Cited by 38 · see citing works
Possible role of dopamine D1 receptors in schizophrenia
Okuba, Y., Suhara, T., Sudo, Y., & Toru, M. (1997) · Molecular Psychiatry · doi:10.1038/sj.mp.4000281 · Cited by 35 · see citing works
Harte, M., & O'Connor, W. T. (2004) · Brain Research · doi:10.1016/j.brainres.2004.05.027 · Cited by 33 · see citing works
Zornoza, T., Cano-Cebrián, M. J., Miquel, M., et al. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300618 · Cited by 26 · see citing works
Exposure to prenatal infections, genetics and the risk of systematic and periodic catatonia
Stöber, G., Franzek, E., Beckmann, H., et al. (2002) · Journal of Neural Transmission · doi:10.1007/s007020200075 · Cited by 26 · see citing works
SCH 23390 in the prefrontal cortex enhances the effect of apomorphine on prepulse inhibition of rats
de Jong, I. E. M., & van den Buuse, M. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.04.002 · Cited by 23 · see citing works
Dean, B., Pavey, G., Scarr, E., et al. (2004) · Life Sciences · doi:10.1016/j.lfs.2003.11.004 · Cited by 16 · see citing works
Xiao (1998) · doi:10.1002/(sici)1098-2396(199808)29:4
Flagged first, then by citations
Cited by
Sorted by citations
Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment
Khandaker, G. M., Cousins, L., Deakin, J., Lennox, B. R., Yolken, R., & Jones, P. B. (2015) · The Lancet Psychiatry · doi:10.1016/s2215-0366(14)00122-9 · Cited by 926 · see citing works
Early-life programming of later-life brain and behavior: a critical role for the immune system
Bilbo, S. D. (2009) · Frontiers in Behavioral Neuroscience · doi:10.3389/neuro.08.014.2009 · Cited by 652 · see citing works
The Role of the Immune System in Autism Spectrum Disorder
Meltzer, A., & Van de Water, J. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.158 · Cited by 533 · see citing works
Beumer, W., Gibney, S. M., Drexhage, R. C., Pont-Lezica, L., Doorduin, J., Klein, H. C., Steiner, J., Connor, T. J., Harkin, A., Versnel, M. A., et al. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.0212100 · Cited by 347 · see citing works
The impact of environmental factors in severe psychiatric disorders
Schmitt, A., Malchow, B., Hasan, A., & Falkai, P. (2014) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00019 · Cited by 322 · see citing works
Reversing behavioural abnormalities in mice exposed to maternal inflammation
Shin Yim, Y., Park, A., Berrios, J., Lafourcade, M., Pascual, L. M., Soares, N., Yeon Kim, J., Kim, S., Kim, H., Waisman, A., et al. (2017) · Nature · doi:10.1038/nature23909 · Cited by 303 · see citing works
Neuroinflammation as a risk factor for attention deficit hyperactivity disorder
Dunn, G. A., Nigg, J. T., & Sullivan, E. L. (2019) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2019.05.005 · Cited by 299 · see citing works
Oskvig, D. B., Elkahloun, A. G., Johnson, K. R., Phillips, T. M., & Herkenham, M. (2012) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.01.015 · Cited by 248 · see citing works
Costello, H., Gould, R. L., Abrol, E., & Howard, R. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-027925 · Cited by 248 · see citing works
Bitanihirwe, B. K., Peleg-Raibstein, D., Mouttet, F., Feldon, J., & Meyer, U. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.129 · Cited by 237 · see citing works
Powell, S. B., Sejnowski, T. J., & Behrens, M. M. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.01.049 · Cited by 164 · see citing works
Marques, A. H., Bjørke-Monsen, A.-L., Teixeira, A. L., & Silverman, M. N. (2015) · Brain Research · doi:10.1016/j.brainres.2014.10.051 · Cited by 166 · see citing works
Microglial activation in a neuroinflammational animal model of schizophrenia – a pilot study
Juckel, G., Manitz, M. P., Brüne, M., Friebe, A., Heneka, M. T., & Wolf, R. J. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.06.018 · Cited by 165 · see citing works
Maternal immune activation in nonhuman primates alters social attention in juvenile offspring
Machado, C. J., Whitaker, A. M., Smith, S. E. P., Patterson, P. H., & Bauman, M. D. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.07.035 · Cited by 136 · see citing works
Developmental vulnerability of synapses and circuits associated with neuropsychiatric disorders
Penzes, P., Buonanno, A., Passafaro, M., Sala, C., & Sweet, R. A. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12261 · Cited by 125 · see citing works
Neuropoietic cytokines in normal brain development and neurodevelopmental disorders
Stolp, H. B. (2013) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2012.08.009 · Cited by 70 · see citing works
Wang, X., Pinto-Duarte, A., Sejnowski, T. J., & Behrens, M. M. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4907 · Cited by 46 · see citing works
Zavitsanou, K., Lim, C. K., Purves-Tyson, T., Karl, T., Kassiou, M., Banister, S. D., Guillemin, G. J., & Weickert, C. S. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.05.011 · Cited by 46 · see citing works
Asp, L., Beraki, S., Kristensson, K., Ögren, S. O., & Karlsson, H. (2009) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2009.04.004 · Cited by 33 · see citing works
Psychiatric aspects of infectious diseases
Mufaddel, A., Omer, A. A., & Salem, M. O. (2014) · Open Journal of Psychiatry · doi:10.4236/ojpsych.2014.43027 · Cited by 14 · see citing works
- Authors
- Meyer, U., & Feldon, J.
- Affiliations
- ETH Zurich (CH)
- Corresponding author
- Meyer, Urs
- Feldon, Joram
- ORCID
- Meyer, Urs
- Venue
- Behavioural Brain Research
- Publisher
- Elsevier BV
- Published
- 2009-12-07
- Volume
- 204
- Issue
- 2
- Pages
- 322-334
- ISSN
- 0166-4328 (ISSN-L)
- OpenAlex
- W2023145239
- Cited by
- 158
- References
- 199
- Citations by year
- 2025: 6 · 2024: 7 · 2023: 3 · 2022: 5 · 2021: 5 · 2020: 10 · 2019: 12 · 2018: 10 · 2017: 7 · 2016: 8 · 2015: 10 · 2014: 11 · 2013: 6 · 2012: 15
- FWCI
- 4.79
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Behavioural Brain Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- schizophrenia, prenatal infection, maternal immune activation, sensorimotor gating, dopaminergic pathways, mesolimbic system, mesocortical pathway, associative learning, working memory, GABAergic dysfunction, glutamatergic dysfunction, prefrontal cortex, hippocampus, neuropathology, environmental risk factors
- MeSH terms
- Animals, Avoidance Learning, Brain, Disease Models, Animal, Dopamine, Female, gamma-Aminobutyric Acid, Neurons, Pregnancy, Pregnancy Complications, Infectious, Prenatal Exposure Delayed Effects, Psychotic Disorders, Schizophrenia, Schizophrenic Psychology, Serotonin, Glutamic Acid, Mice, Rats, Sensory Gating
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review